Posted inNews and Updates
Kalshi Launches Biotech Betting Markets on Clinical Trials
Kalshi enters the biotech sector with new prediction markets for clinical trial outcomes. Discover the implications for investors and the medical industry.
Posted inNews and Updates
Prediction Markets Emerge to Forecast Clinical Trial Success
New prediction markets allow traders to bet on clinical trial results and FDA approvals. Explore how these financial tools are changing biopharma R&D.
Posted inNews and Updates
Lilly to Acquire Atai-Beckley in Mental Health Push
Eli Lilly acquires Atai-Beckley to innovate treatments for resistant depression and mental health. Discover how this move aims to transform psychiatric care.
Posted inNews and Updates
MN-166 ALS Trial: MediciNova Reaches Enrollment Milestone
MediciNova completes enrollment for the SEANOBI-ALS trial of MN-166. Explore how this potential neuroprotective therapy could change ALS treatment.
Posted inNews and Updates
Integrating Patient Partners in Long-Term Clinical Research
Explore the critical lessons learned from integrating Patient Research Partners into a 7-year clinical study to improve research design and retention.
Posted inNews and Updates
Congo Begins Clinical Trials of Gilead Drug for Ebola
Congo has launched a new clinical trial testing a Gilead antiviral as a post-exposure treatment for Ebola. Discover the potential impact on viral control.
Posted inNews and Updates
Cannabis-Based Drug Shows Potential for Dementia Agitation
New clinical research reveals that a cannabis-based treatment may effectively reduce agitation in dementia patients, offering a safer alternative to sedation.
Posted inNews and Updates
Vivani Medical Plans Semaglutide Implant Trials for August
Vivani Medical targets August for human trials of its new semaglutide implant. Learn how this novel delivery system could revolutionize metabolic care.
Posted inNews and Updates
Stanford-Harvard Study Ranks Clinical AI Safety Leaders
A major study by Stanford and Harvard experts ranks Doximity as a leader in clinical AI safety, highlighting critical gaps in current healthcare technology.
Posted inNews and Updates
FAST-02 Trial: Novel Radiation Therapy for Bone Metastases
The FAST-02 clinical trial confirms that rapid, targeted radiation therapy provides significant pain relief for patients with chest wall bone metastases.